{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T22:27:36Z","timestamp":1783636056217,"version":"3.55.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:00:00Z","timestamp":1776729600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:00:00Z","timestamp":1780358400000},"content-version":"vor","delay-in-days":42,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"DOI":"10.1007\/s10875-026-02019-9","type":"journal-article","created":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T02:33:05Z","timestamp":1776738785000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Phenotypic Heterogeneity in CD40 Ligand Deficiency: Long-term Follow-up of a Patient with the c.156G\u2009>\u2009A Splice Variant"],"prefix":"10.1007","volume":"46","author":[{"given":"Fayhan","family":"Alroqi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulrahman N.","family":"AlJaber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nouf","family":"Althubaiti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abeer","family":"Al Tuwaijri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shouq","family":"Alzaaqi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tlili","family":"Barhoumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abduarahman","family":"Almutairi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bader","family":"Almuzzaini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leena","family":"Alsayegh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maysa","family":"Nogoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Modhi","family":"Aljedaie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,21]]},"reference":[{"key":"2019_CR1","doi-asserted-by":"publisher","unstructured":"- Chapel H, Prevot J, Gaspar HB et al. Primary immune deficiencies - principles of care. Front Immunol. 2014;5:627. Published 2014 Dec 15. https:\/\/doi.org\/10.3389\/fimmu.2014.00627","DOI":"10.3389\/fimmu.2014.00627"},{"issue":"1","key":"2019_CR2","doi-asserted-by":"publisher","first-page":"e20250003","DOI":"10.70962\/jhi.20250003","volume":"1","author":"MC - Poli","year":"2025","unstructured":"- Poli MC, Aksentijevich I, Bousfiha AA, et al. Human inborn errors of immunity: 2024 update on the classification from the International Union of Immunological Societies Expert Committee. J Hum Immun. 2025;1(1):e20250003. https:\/\/doi.org\/10.70962\/jhi.20250003. Published 2025 Apr 15.","journal-title":"J Hum Immun"},{"issue":"3","key":"2019_CR3","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1046\/j.1365-2249.2000.01142.x","volume":"120","author":"LD - Notarangelo","year":"2000","unstructured":"- Notarangelo LD, Hayward AR. X-linked immunodeficiency with hyper-IgM (XHIM). Clin Exp Immunol. 2000;120(3):399\u2013405. https:\/\/doi.org\/10.1046\/j.1365-2249.2000.01142.x.","journal-title":"Clin Exp Immunol"},{"issue":"6","key":"2019_CR4","doi-asserted-by":"publisher","first-page":"2170","DOI":"10.1073\/pnas.90.6.2170","volume":"90","author":"R - Fuleihan","year":"1993","unstructured":"- Fuleihan R, Ramesh N, Loh R, et al. Defective expression of the CD40 ligand in X chromosome-linked immunoglobulin deficiency with normal or elevated IgM. Proc Natl Acad Sci U S A. 1993;90(6):2170\u20133. https:\/\/doi.org\/10.1073\/pnas.90.6.2170.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2019_CR5","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.clim.2018.11.007","volume":"198","author":"R - Yazdani","year":"2019","unstructured":"- Yazdani R, Fekrvand S, Shahkarami S, et al. The hyper IgM syndromes: Epidemiology, pathogenesis, clinical manifestations, diagnosis and management. Clin Immunol. 2019;198:19\u201330. https:\/\/doi.org\/10.1016\/j.clim.2018.11.007.","journal-title":"Clin Immunol"},{"issue":"1","key":"2019_CR6","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1111\/j.1600-065X.2009.00782.x","volume":"229","author":"R - Elgueta","year":"2009","unstructured":"- Elgueta R, Benson MJ, de Vries VC, Wasiuk A, Guo Y, Noelle RJ. Molecular mechanism and function of CD40\/CD40L engagement in the immune system. Immunol Rev. 2009;229(1):152\u201372. https:\/\/doi.org\/10.1111\/j.1600-065X.2009.00782.x.","journal-title":"Immunol Rev"},{"key":"2019_CR7","doi-asserted-by":"publisher","unstructured":"- Zhang K, Kang L, Zhang H et al. A synonymous mutation in PI4KA impacts the transcription and translation process of gene expression. Front Immunol. 2022;13:987666. Published 2022 Oct 19. https:\/\/doi.org\/10.3389\/fimmu.2022.987666","DOI":"10.3389\/fimmu.2022.987666"},{"issue":"8","key":"2019_CR8","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1007\/s10875-022-01329-y","volume":"42","author":"U - Fran\u00e7oise","year":"2022","unstructured":"- Fran\u00e7oise U, Lafont E, Suarez F, Lanternier F, Lortholary O. Disseminated Cryptococcosis in a Patient with CD40 Ligand Deficiency. J Clin Immunol. 2022;42(8):1622\u20135. https:\/\/doi.org\/10.1007\/s10875-022-01329-y.","journal-title":"J Clin Immunol"},{"issue":"3","key":"2019_CR9","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1073\/pnas.98.3.1166","volume":"98","author":"S - Weller","year":"2001","unstructured":"- Weller S, Faili A, Garcia C, et al. CD40-CD40L independent Ig gene hypermutation suggests a second B cell diversification pathway in humans. Proc Natl Acad Sci U S A. 2001;98(3):1166\u201370. https:\/\/doi.org\/10.1073\/pnas.98.3.1166.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"2019_CR10","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s13059-022-02664-4","volume":"23","author":"T - Zeng","year":"2022","unstructured":"- Zeng T, Li YI. Predicting RNA splicing from DNA sequence using Pangolin. Genome Biol. 2022;23(1):103. https:\/\/doi.org\/10.1186\/s13059-022-02664-4. Published 2022 Apr 21.","journal-title":"Genome Biol"},{"key":"2019_CR11","unstructured":"- JSI medical systems GmbH. varSEAK. Ettenheim, Germany. https:\/\/www.varseak.bio. Accessed September 22, 2025."},{"issue":"2","key":"2019_CR12","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1093\/intimm\/5.2.233","volume":"5","author":"MC - Peitsch","year":"1993","unstructured":"- Peitsch MC, Jongeneel CV. A 3-D model for the CD40 ligand predicts that it is a compact trimer similar to the tumor necrosis factors. Int Immunol. 1993;5(2):233\u20138. https:\/\/doi.org\/10.1093\/intimm\/5.2.233.","journal-title":"Int Immunol"},{"issue":"5","key":"2019_CR13","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1002\/pro.5560070506","volume":"7","author":"J - Singh","year":"1998","unstructured":"- Singh J, Garber E, Van Vlijmen H, et al. The role of polar interactions in the molecular recognition of CD40L with its receptor CD40. Protein Sci. 1998;7(5):1124\u201335. https:\/\/doi.org\/10.1002\/pro.5560070506.","journal-title":"Protein Sci"},{"key":"2019_CR14","doi-asserted-by":"publisher","unstructured":"- Fran\u00e7a TT, Leite LFB, Maximo TA et al. A Novel de Novo Mutation in the CD40 Ligand Gene in a Patient With a Mild X-Linked Hyper-IgM Phenotype Initially Diagnosed as CVID: New Aspects of Old Diseases. Front Pediatr. 2018;6:130. Published 2018 May 4. https:\/\/doi.org\/10.3389\/fped.2018.00130","DOI":"10.3389\/fped.2018.00130"},{"issue":"4","key":"2019_CR15","doi-asserted-by":"publisher","first-page":"e12798","DOI":"10.1111\/sji.12798","volume":"90","author":"X - Du","year":"2019","unstructured":"- Du X, Tang W, Chen X, et al. Clinical, genetic and immunological characteristics of 40 Chinese patients with CD40 ligand deficiency. Scand J Immunol. 2019;90(4):e12798. https:\/\/doi.org\/10.1111\/sji.12798.","journal-title":"Scand J Immunol"},{"issue":"7","key":"2019_CR16","doi-asserted-by":"publisher","first-page":"2421","DOI":"10.1182\/blood.V92.7.2421","volume":"92","author":"K - Seyama","year":"1998","unstructured":"- Seyama K, Nonoyama S, Gangsaas I, et al. Mutations of the CD40 ligand gene and its effect on CD40 ligand expression in patients with X-linked hyper IgM syndrome. Blood. 1998;92(7):2421\u201334.","journal-title":"Blood"},{"issue":"5","key":"2019_CR17","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1182\/blood-2003-12-4420","volume":"105","author":"WI - Lee","year":"2005","unstructured":"- Lee WI, Torgerson TR, Schumacher MJ, Yel L, Zhu Q, Ochs HD. Molecular analysis of a large cohort of patients with the hyper immunoglobulin M (IgM) syndrome. Blood. 2005;105(5):1881\u201390. https:\/\/doi.org\/10.1182\/blood-2003-12-4420.","journal-title":"Blood"},{"issue":"3","key":"2019_CR18","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.clim.2005.08.005","volume":"117","author":"F - Blaeser","year":"2005","unstructured":"- Blaeser F, Kelly M, Siegrist K, et al. Critical function of the CD40 pathway in parvovirus B19 infection revealed by a hypomorphic CD40 ligand mutation. Clin Immunol. 2005;117(3):231\u20137. https:\/\/doi.org\/10.1016\/j.clim.2005.08.005.","journal-title":"Clin Immunol"},{"issue":"4","key":"2019_CR19","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/s10875-007-9089-8","volume":"27","author":"S - Danielian","year":"2007","unstructured":"- Danielian S, Oleastro M, Eva Rivas M, Cantisano C, Zelazko M. Clinical follow-up of 11 Argentinian CD40L-deficient patients with 7 unique mutations including the so-called milder mutants. J Clin Immunol. 2007;27(4):455\u20139. https:\/\/doi.org\/10.1007\/s10875-007-9089-8.","journal-title":"J Clin Immunol"},{"issue":"11","key":"2019_CR20","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1136\/jcp.2008.058362","volume":"61","author":"PF - Yong","year":"2008","unstructured":"- Yong PF, Post FA, Gilmour KC, et al. Cerebral toxoplasmosis in a middle-aged man as first presentation of primary immunodeficiency due to a hypomorphic mutation in the CD40 ligand gene. J Clin Pathol. 2008;61(11):1220\u20132. https:\/\/doi.org\/10.1136\/jcp.2008.058362.","journal-title":"J Clin Pathol"},{"issue":"1","key":"2019_CR21","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1007\/s10875-011-9607-6","volume":"32","author":"S - Kiani-Alikhan","year":"2012","unstructured":"- Kiani-Alikhan S, Yong PF, Gilmour KC, Grosse-Kreul D, Davies EG, Ibrahim MA. Phenotypic heterogeneity in a family with a CD40 ligand intracellular domain mutation. J Clin Immunol. 2012;32(1):70\u20137. https:\/\/doi.org\/10.1007\/s10875-011-9607-6.","journal-title":"J Clin Immunol"},{"issue":"10","key":"2019_CR22","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1038\/nrg3051","volume":"12","author":"ZE - Sauna","year":"2011","unstructured":"- Sauna ZE, Kimchi-Sarfaty C. Understanding the contribution of synonymous mutations to human disease. Nat Rev Genet. 2011;12(10):683\u201391. https:\/\/doi.org\/10.1038\/nrg3051. Published 2011 Aug 31.","journal-title":"Nat Rev Genet"},{"key":"2019_CR23","doi-asserted-by":"publisher","unstructured":"- Oelschlaeger P. Molecular Mechanisms and the Significance of Synonymous Mutations. Biomolecules. 2024;14(1):132. Published 2024 Jan 20. https:\/\/doi.org\/10.3390\/biom14010132","DOI":"10.3390\/biom14010132"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10875-026-02019-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-026-02019-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-026-02019-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T09:15:06Z","timestamp":1780391706000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10875-026-02019-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,21]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2019"],"URL":"https:\/\/doi.org\/10.1007\/s10875-026-02019-9","relation":{},"ISSN":["1573-2592"],"issn-type":[{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,21]]},"assertion":[{"value":"28 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"This study was conducted in accordance with the principles of the Declaration of Helsinki. Written informed consent was obtained from the patient and family members for genetic testing, immunological investigations, and publication of clinical data. The study was approved by the Institutional Review Board at King Abdullah International Medical Research Center (IRB: NRR24\/083\/12).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Statement"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}],"article-number":"59"}}